O'Neill Julie 4
4 · ALEXION PHARMACEUTICALS INC · Filed Sep 5, 2017
Insider Transaction Report
Form 4
O'Neill Julie
EVP. Global Operations
Transactions
- Sale
Common Stock, par value $.0001 per share
2017-08-31$142.00/sh−612$86,904→ 26,092 total - Sale
Common Stock, par value $.0001 per share
2017-09-05$147.00/sh−672$98,784→ 23,579 total - Sale
Common Stock, par value $.0001 per share
2017-09-05$145.81/sh−1,841$268,436→ 24,251 total - Sale
Common Stock, par value $.0001 per share
2017-09-05$145.81/sh−650$94,777→ 22,329 total - Sale
Common Stock, par value $.0001 per share
2017-09-05$145.64/sh−600$87,384→ 22,979 total
Footnotes (4)
- [F1]The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $142.00 - $142.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $145.51 - $146.51. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F4]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.